PDS5B and acute myeloid leukemia: Nine mice engrafted with patient AML blasts were treated with either anti-HOXB-AS3 gapmers (n = 5) or scramble control (n = 4) for 2 weeks for evaluation of the in vivo HOXB-AS3 KD efficacy.